
    
      This study has two parts:

      Part A - single ascending dose of LY3006072 administered to healthy participants in 3 of 4
      study periods (placebo in 1 of 4 periods).

      Part B - morning and evening doses of LY3006072 given to healthy participants in fed and
      fasted states in 2 or 3 of 3 study periods (placebo in 1 of 3 periods for some participants).
    
  